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Abstract
H9-T-cells do not support the replication of mutant HIV-1 encoding Env protein lacking its long
cytoplasmic C-terminal domain (Env-CT). Here we describe the generation of a H9-T-cell
population constitutively expressing the HIV-1 Env-CT protein domain anchored in the cellular
membrane by it homologous membrane-spanning domain (TMD). We confirmed that the Env-
TMD-CT protein was associated with cellular membranes, that its expression did not have any
obvious cytotoxic effects on the cells and that it did not affect wild-type HIV-1 replication.
However, as measured in both a single-round assay as well as in spreading infections, replication
competence of mutant pNL-Tr712, lacking the Env-CT, was not restored in this H9 T-cell
population. This means that the Env-CT per se cannot transcomplement the replication block of
HIV-1 virions encoding C-terminally truncated Env proteins and suggests that the Env-CT likely
exerts its function only in the context of the complete Env protein.
Findings
In contrast to most other enveloped viruses, the surface
Env glycoproteins of lentiviruses, including HIV-1, con-
tain very long C-terminal cytoplasmic tails (CTs). In the
case of HIV-1, the Env-CT has a conserved length of about
150 amino acids (aa) and mutant viruses, encoding trun-
cated Env proteins, are unable to replicate in most T cell-
lines [1]. However, despite its undoubted importance for
the HIV-1 life cycle, the biological mechanism by which
the long Env-CT facilitates virus replication is still not
fully understood. Numerous studies employing HIV Env-
CT mutants have addressed the potential roles of various
motifs and features within the Env-CT. Of relevance for
this study is the fact the Env-CT may impact cellular phe-
nomena. Thus, for example, the HIV-Env-CT has been
reported to bind to calmodulin and to inhibit calmodu-
lin-regulated proteins [2,3]. Furthermore, yeast 2 hybrid
screenings have identified further potential cellular inter-
action partners of the HIV-Env-CT. These are α-catenin,
which is involved in cellular adhesion [4,5], and p115-
RhoGEF, which regulates actin stress fiber formation and
activates the serum response factor (SRF) [6]. It is possible
that these interactions with cellular processes, or others
presently unknown, are important for viral replication.
For example, it is conceivable that the Env-CT itself
accesses signal transduction pathways to alter cellular
gene expression and facilitate virus replication or, alterna-
tively, membrane-bound Env-CT itself may recruit essen-
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Generation of, and virus replication in, an H9 T-cell population stably expressing HIV-Env-TMD-CT Figure 1
Generation of, and virus replication in, an H9 T-cell population stably expressing HIV-Env-TMD-CT. A. schematic representa-
tion of the SIN lentiviral vector pWPI-Env-TMD-CT employed. An internal human EF1-α promoter drives expression of a tran-
scriptional unit consisting of the Env-TMD-CT gene, an IRES element and the gene for GFP. The composition of the Env-TMD-
CT gene is described in the text. SP; signal peptide sequence of tissue plasminogen activator, Env-TMD; membrane anchor of 
HIV-Env, CT; cytoplasmic domain of HIV-Env. B. FACS for GFP expression (left panels) and indirect immunofluorescence anal-
yses for Env-TMD-CT expression (right panels) of H9 T-cell populations stably transduced with pWPI (H9-GFP) and pWPI-
Env-TMD-CT vector particles (H9-CT). Immunofluorescence of paraformaldehyde-fixed permeabilised H9 cells was per-
formed with rabbit anti-gp160 serum shown to contain antibodies against the Env CT, followed by biotinylated goat anti-rabbit 
IgG and streptavidin phycoerythrin. Identical exposure times were used to generate the images from the H9-GFP and the H9-
CT cells. C. Western blot analysis of H9 cells stably transduced with pWPI (H9-GFP) and pWPI-Env-TMD-CT (H9-CT) (left 
panel) and of cytosolic (C) and membrane (M) fractions of H9-CT cells (right panel) with gp41 Mab Chessie 8 [16] as indicated. 
After stripping, the right blot was reprobed with rabbit antibodies specific for the cytoplasmic protein 14-3-3 γ (C-16) (Santa 
Cruz Biotechnology). D. Replication kinetics of Wt-pNL-4-3 (Wt) (filled-in symbols) and pNL-Tr712 virions (Tr712) (empty 
symbols) in H9 cells (circles), H9-GFP cells (triangles) and H9-CT cells (squares). Infections were initiated with 100 ng virus per 
106 cells, produced by transfection of the respective plasmids in 293T cells. 5 h p.i., the cells were thoroughly washed and the 
course of infections followed by measurement of newly released HIV-CA in the supernatant by ELISA. E. Western blot analyses 
of equalised amounts (by CA-ELISA of culture supernatants) of lysates of H9-GFP and H9-CT cells infected with pNL-∆ Env 
(∆), pNL-Wt (Wt) and pNL-Tr712 (712) (left) and of equalised amounts (by CA-ELISA of ultracentrifuged particles) of the 
respective virions released into the media (right). The top portions of the filters have been probed with anti-gp120 serum and 
the bottom portion with anti-CT antibodies (Chessie 8).
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tial cellular proteins to cellular membranes sites and thus
facilitate virus assembly and release.
In this study, we have generated and characterised H9 T-
cells which stably express a membrane-bound version of
the Env-CT and examined if the presence of this region
alone might be sufficient for the transcomplementation of
originally non-infectious HIV-1 virions encoding for trun-
cated Env glycoproteins.
pWPI-Env-TMD-CT, depicted in Fig 1A, encodes a mem-
brane-bound form of the Env-CT and is based on the
bicistronic lentiviral vector pWPI (obtained from D.
Trono, University of Geneva, Switzerland). pWPI-Env-
TMD-CT and pWPI additionally express green fluorescent
protein (GFP) downstream of an internal ribosomal entry
site (IRES). The Env-TMD-CT gene consists of the signal
peptide (SP) sequence from tissue plasminogen activator
(tPA) (tPA amino acids (aa) 1–35) fused via a 4aa spacer
to the membrane-spanning (TMD) and CT domains of
the HIV BH10-Env protein (aa 684–851). The 4aa spacer
consists of 2 HIV-Env aa (Thr, Glu) C-terminal to the HIV-
SP cleavage site and 2 HIV-Env aa N-terminal to the TMD
(Ile, Lys).
Lentiviral vector particles were generated by cotransfec-
tion of 293T cells with pWPI-Env-TMD-CT or, as a con-
trol, pWPI plus the packaging construct pCMV∆R8.91 [7]
and the VSV-G expression plasmid pMD.G [8]. Vector par-
ticles, concentrated from the culture supernatant by ultra-
centrifugation, were employed to transduce H9 cells.
Transduced cell populations were then sorted for maxi-
mum GFP expression and expanded. The resulting trans-
duced populations were designated H9-CT cells
(expressing Env-TMD-CT and GFP) and H9-GFP cells
(expressing only GFP). As shown in Fig. 1B, both popula-
tions were over 90% positive for GFP expression although
clearly the fluorescence intensity of the H9-CT population
was lower than that of the H9-GFP population. This may
be a result of GFP expression being decreased when pre-
ceded by the Env-TMD-CT gene. Expression of the Env-
TMD-CT protein in the sorted H9-CT population was first
analysed by indirect immunofluorescence of paraformde-
hyde-fixed, permeabilised cells employing rabbit anti-
gp160 serum which we have previously demonstrated to
contain antibodies against the Env-CT. As shown in Fig.
1B, right panels, in comparison to H9-GFP cells, virtually
all of the cells in the H9-CT culture were positive for Env-
TMD-CT expression. Western blot analysis confirmed
expression of a specific Env-TMD-CT protein band migrat-
ing at about the position of its calculated molecular
weight (18.8 kDa after removal of the SP) (Fig. 1C, left
panel). In addition, some minor species migrating slightly
slower or faster than the major Env-TMD-CT protein,
which may represent species still containing the SP or deg-
radation products, respectively, were detectable. In order
to confirm localisation to cellular membranes, cytosolic
(C) and membrane (M) fractions from H9-CT cells were
prepared employing published procedures [9]. Western
blot analysis of equivalent amounts of these fractions
demonstrated that the Env-TMD-CT protein was localised
predominantly in the membrane fraction and only a
minor amount remained in the cytosolic fraction (Fig. 1C,
right panels). Reprobing the blot with antibodies to the
30 kDa cytosolic protein 14-3-3 γ (C-16) [10] confirmed
the authenticity of the membrane/cytosol separation. In
summary, these results point to functional membrane
insertion of the Env-TMD-CT protein.
There were no obvious cytotoxic effects on the H9-CT cells
as a result of expression of the Env-TMD-CT protein. Thus
cell growth was not reduced in comparison to H9-GFP
cells and cell morphology was unaffected (data not
shown). We then went on to examine the replication of
wild-type HIV (pNL4-3, referred to as pNL-Wt) and
mutant pNL-Tr712, encoding truncated Env protein in
which only 7aa of the 151 aa long Env-CT remain [11], in
H9, H9-GFP and H9-CT cells. The viruses were generated
by transfection of the respective proviral plasmids in 293T
cells and amounts equivalent to 100 ng CA/106 cells, as
determined by enzyme-linked immunosorbant assay
(ELISA) (Innogenetics, Ghent, Belgium) were used to ini-
tiate infection of the H9 cell populations. After removing
input virus and thorough washing, the course of the infec-
tions was monitored by determining, via CA-ELISA, the
amounts of released virions in the respective culture
supernatants over time. As shown in Fig. 1D, pNL-Wt
virus replicated efficiently in all the H9 cell populations
but with a slight delay in both H9-CT and H9-GFP cells.
The basis for this slight delay in replication kinetics is not
known. As had been shown previously [1], pNL-Tr712
cannot give rise to a spreading infection in H9 cells nor, as
to be expected, was this the case in H9-GFP cells. In the
H9-CT cell population, spreading infection of pNL-Tr712
virus also does not occur despite the presence of the Env-
CT region anchored at the cellular membrane by its
homologous TMD.
In order to generate virions for further analyses, the
respective H9 cell populations were infected with VSV-G
pseudotyped pNL-Wt, pNL-Tr712 virions and pNL-∆ Env
virions using procedures previously described [12] and,
after removal of input virus, the respective newly gener-
ated virions were collected. The infectivities of the virions
in the supernatants of the infected H9 cells were analysed
in a single-round assay in Tzm-bl reporter cells [13-15].
pNL-Tr712 virions exhibited reduced but still significant
infectivity in comparison to pNL-Wt virions but the extent
of the reduction was independent of whether the virions
were produced in H9-GFP cells or in H9-CT cells express-Retrovirology 2006, 3:27 http://www.retrovirology.com/content/3/1/27
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ing membrane-bound Env-TMD-CT (data not shown).
This shows that the expression of the Env-TMD-CT pro-
tein in producer H9 T-cells does not result in an increase
of the infectivity of released pNL-Tr712 virions. In order
to examine if the Env-TMD-CT protein, expressed in the
H9-CT cells, was incorporated into released virions, the
respective virions were concentrated by ultracentrifuga-
tion from the media of infected H9-CT cells or H9-GFP
cells and lysates of infected cells and virions examined in
Western blot (Fig. 1E). Virally-expressed gp160, gp120
and gp41 were detectable in lysates of pNL-Wt infected
cells and truncated gp160 (gp140) and gp120 in lysates of
pNL-Tr712 infected cells. The truncated gp41 species
(gp28) expressed by pNL-Tr712 was not detected since the
antibodies employed (Chessie 8 [16]) bind to an epitope
in the Env-CT missing in this protein. In the lysates of all
the infected H9-CT cultures, constitutively expressed Env-
TMD-CT protein was detectable. Its expression level was
similar to that of the gp41 protein expressed after infec-
tion with pNL-Wt. In Fig. 1E, right panel, analysis of
equalised amounts (by CA-ELISA) of virions concentrated
from the supernatants of the respective infected cultures is
shown. Gp120 and gp41 proteins were detectable in pNL-
Wt virions and gp120 protein was detectable in pNL-
Tr712 virions (again the truncated gp28 band cannot be
detected). This observation of gp120 incorporation into
pNL-Tr712 virions stands in contrast to two studies in the
literature [1,17] which report that Env incorporation into
pNL-Tr712 virions is defective when these are produced in
non-permissive cells. However, we consistently observe
gp120 incorporation into pNL-Tr712 and have recently
reported that this is also the case with another mutant HIV
encoding Env with a different C-terminal truncation [12].
The reason for this discrepancy is presently unknown. Of
interest in the context of this report is the fact that,
although the respective virions have incorporated gp120/
gp41, the constitutively expressed Env-TMD-CT protein
was not detectable in any of the released virions. The phe-
nomena which determine if particular cellular and viral
proteins are incorporated into virions or not are not
understood in depth. Thus also in this case, we can only
speculate that perhaps the Env-TMD-CT protein may not
be localised at the cellular sites of virus assembly or may
not appropriately interact with cellular proteins influenc-
ing localisation/incorporation.
In summary, in this report we describe a cell population
in which the majority, and likely all of the cells express a
native i.e. untagged version of the HIV-Env-CT domain
anchored in their cellular membranes by its homologous
membrane anchor. We envisage that the expressed Env-
TMD-CT protein likely adopts its native conformation
although we cannot formally rule out the possibility that
this may require the presence of the Env ectodomain. The
presence of the membrane-bound Env-TMD-CT protein
in the H9 cells was not sufficient to transcomplement the
replication block of virions encoding C-terminally trun-
cated Env proteins. Although other reasons may account
for this lack of transcomplementation, the most likely
explanation is that the Env-TMD-CT has to be part of the
full-length Env protein in order to fulfill its essential func-
tion(s). Nevertheless, H9 CT cells (and control H9-GFP
cells) may still be useful tools to study possible effects of
the Env-TMD-CT protein on cellular processes such as sig-
nal transduction phenomena/cellular gene expression.
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